Clinical Trial Update: Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID [NA]

View source ↗

Summary

A double-blind randomized placebo-controlled trial of a proprietary full hemp flower formulation for post-acute COVID-19 syndrome has been withdrawn from the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Full hemp flower formulation

Snippet

Sponsor: LUCINDA BATEMAN, MD | Conditions: Post-acute COVID-19 Syndrome | NA | Status: WITHDRAWN